Association between serum haptoglobin and carotid arterial functions: usefulness of a targeted metabolomics approach

Abstract

BackgroundSerum haptoglobin (Hp) has been closely associated with cardio-cerebrovascular diseases. We investigated a metabolic profile associated with circulating Hp and carotid arterial functions via a targeted metabolomics approach to provide insight into potential mechanisms.MethodsA total of 240 participants, including 120 patients with type 2 diabetes mellitus (T2DM) and 120 non-diabetes mellitus (non-DM) subjects were recruited in this study. Targeted metabolic profiles of serum metabolites were determined using an AbsoluteIDQ™ p180 Kit (BIOCRATES Life Sciences AG, Innsbruck, Austria). Ultrasound of the bilateral common carotid artery was used to measure intima-media thickness and inter-adventitial diameter. Serum Hp levels were tested by enzyme-linked immunosorbent assay.ResultsSerum Hp levels in T2DM patients and non-DM subjects were 103.40 (72.46, 131.99) mg/dL and 100.20 (53.99, 140.66) mg/dL, respectively. Significant differences of 19 metabolites and 17 metabolites were found among serum Hp tertiles in T2DM patients and non-DM subjects, respectively (P < 0.05). Of these, phosphatidylcholine acyl-alkyl C32:2 (PC ae C32:2) was the common metabolite observed in two populations, which was associated with the serum Hp groups and lipid traits (P < 0.05). Furthermore, the metabolite ratios of two acidic amino acids, including aspartate to PC ae C32:2 (Asp/PC ae C32:2) and glutamate to PC ae C32:2 (Glu/PC ae C32:2) were correlated with serum Hp, carotid arterial functions and other biochemical index in both populations significantly (P < 0.05).ConclusionsTargeted metabolomics analyses might provide a new insight into the potential mechanisms underlying the association between serum Hp and carotid arterial functions.Electronic supplementary materialThe online version of this article (10.1186/s12933-019-0808-2) contains supplementary material, which is available to authorized users.

The effect of haptoglobin genotype on the association of asymmetric dimethylarginine and DDAH 1 polymorphism with diabetic macroangiopathy

“…A total of 184 metabolites, including 21 amino acids, 21 biogenic amines, 1 hexose, 40 acylcarnitines, 87 glycerophospholipids [14 lyso-phosphatidylcholines (lysoPCs) and 73 phosphatidylcholines (PCs)], and 14 sphingolipids (SMs) were measured using this kit. The assay procedures followed the manufacturer's instructions, and the metabolite nomenclature has been previously described in detail [19]. Amino acids and biogenic amines were quantified by liquid chromatography-tandem mass spectrometry using internal standards, whereas flow injection analysis-tandem mass spectrometry was applied for acylcarnitines, glycerophospholipids, SMs, and hexoses.…”

Decreased Circulating Very Small Low-Density Lipoprotein is Likely Causal for Age-Related Macular Degeneration

“…Of note, the study of metabolite derivatives and ratios provided invaluable insights into relationships that exist between individual metabolites, enzymatic processes, and clinically useful biomarkers. 32 , 33 Investigating the clinical lipids measured by NMR platform in this study in addition to investigating derivatives and metabolite ratios may shed light on dynamic changes in metabolite levels in AMD and help target clinically relevant metabolites.…”

A dual-quenched ECL immunosensor for ultrasensitive detection of retinol binding protein 4 based on luminol@AuPt/ZIF-67 and MnO2@CNTs

“…Retinol binding protein 4 (RBP4), an insulin resistance-related hormone, is a potential serological biomarker for early monitoring and diagnosis of T2DM [5][6][7]. However, conventional RBP4 quantitative detection methods, such as enzyme immunoassay (EIA) [8], enzyme linked immunosorbent assay (ELISA) [9], and radioimmunoassay [10], usually suffer from insufficient sensitivity, expensive experimental facilities and complicated operation procedures. Thus, in order to address the aforementioned challenges, establishing effective RBP4 analysis strategy with the advantages of easy manipulation, high sensitivity, and low cost remains urgent requirement for modern clinical diagnosis of T2DM.…”